Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma

Pediatric Pulmonology

Volumn 29, Issue 6, 2000, Pages 415-423

  Hofstra, Winfried B ^a   Neijens, Herman J ^b   Duiverman, Eric J ^c,g   Kouwenberg, Jan M ^a   Mulder, Paul G H ^d   Kuethe, Maarten C ^e   Sterk, Peter J ^f  

^a JULIANA CHILDREN S HOSPITAL   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e T Lange Land Ziekenhuis   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Bronchial hyperresponsiveness; Children; Eosinophil cationic protein; Exercise induced asthma; Fluticasone propionate; Inhaled corticosteroids; Randomized clinical trial

Indexed keywords

CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE PROPIONATE; METHACHOLINE; PLACEBO;

ARTICLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; EXERCISE INDUCED ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADMINISTRATION, INHALATION; ADOLESCENT; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; ASTHMA, EXERCISE-INDUCED; BRONCHOCONSTRICTION; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHACHOLINE CHLORIDE;

EID: 0034044379     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(200006)29:6<415::AID-PPUL1>3.0.CO;2-7     Document Type: Article

References (41)

1. NHBLI/WHO. Global strategy for asthma management and prevention, NHBLI/WHO Workshop report. NIH Publication no. 96-3659B. NIH; 1995.
2. Holgate ST. The inflammatory basis of asthma and its implications for drug treatment. Clin Exp Allergy [Suppl] 1996;26:1-4.
3. Ferguson AC, Whitelaw M, Brown H. Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with astma. J Allergy Clin Immunol 1992; 90:609-613.
4. Chetta A, Foresi A, Del Donno M, Consigli GF, Bertorelli G, Pesci A, Barbee RA, Olivieri D. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma. Am J Respir Crit Care Med 1996;153:910-917.
5. Pauwels R, Joos G, Van der Straeten M. Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma. Clin Allergy 1988;18:317-321.
6. Godfrey S, Bar-Yishay E. Exercise-induced asthma revisited. Respir Med 1993;87:331-344.
7. Makker HK, Holgate ST. Mechanisms of exercise-induced asthma. Eur J Clin Invest 1994;24:571-585.
8. Venge P, Henriksen J, Dahl R. Eosinophils in exercise-induced asthma. J Allergy Clin Immunol 1991;88:699-704.
9. Yoshikawa T, Shoji S, Fujii T, Kanazawa H, Kudoh S, Hirata K, Yoshikawa J. Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma. Eur Respir J 1998;12:879-884.
10. Barnes PJ. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma. J Allergy Clin Immunol 1998;101:427-433.
11. Calpin C, Macarthur C, Stephens D, Feldman W, Parkin PC. Effectiveness of prophylactic inhaled steroids in childhood asthma: a systematic review of the literature. J Allergy Clin Immunol 1997;100:452-457.
12. Trigg CJ, Manolitsas ND, Wang J, Calderon MA, McAulay A, Jordan SE, Herdman MJ, Jhalli N, Duddle JM, Hamilton SA, Devalia JL, Davies RJ. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994;150:17-22.
13. Henriksen JM, Dahl R. Effects of inhaled budesonide alone and in combination with low-dose terbutaline in children with exercise-induced asthma. Am Rev Respir Dis 1983;128:993-997.
14. Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol 1995;95:29-33.
15. Jonasson G, Carlsen K-H, Blomqvist P. Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids. Eur Respir J 1998; 12:1099-1104.
16. Kraan J, Koëter GH, Van der Mark TW, Boorsma M, Kukler J, Sluiter HJ, De Vries K. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis 1988;137: 44-48.
17. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma. Thorax 1991;146:811-816.
18. Van Essen-Zandvliet EEM, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF, Dutch Chronic Non-specific Lung Disease Study Group. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis 1992;146:547-554.
19. Waalkens HJ, van Essen-Zandvliet EEM, Gerritsen J, Duiverman EJ, Kerrebijn KF, Knol K. The effect of an inhaled corticosteroid (budesonide) on exercise-induced asthma in children. Eur Respir J 1993;6:652-656.
20. Turktas I, Demirsoy S, Koc E, Gokcora N, Elbeg S. Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor for IgE (FceRII/sCD23) in childhood bronchial asthma. Arch Dis Child 1996;75:314-318.
21. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents: methods and reference values. Prog Respir Res 1987; 22:83-112.
22. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Standardized lungfunction testing. Lung volumes and forced ventilatory flows. Eur Respir J [Suppl] 1993;6:5-40.
23. Merkus PJFM, Eelkman Roorda HM, Van Essen-Zandvliet EEM, Duiverman EJ, Quanjer PH, Kerrebijn KF. Assessment of bronchodilatation following spontaneous recovery from a histamine challenge in asthmatic children. Thorax 1992;47:355-359.
24. Hofstra WB, Sont JK, Sterk PJ, Neijens HJ, Kuethe MC, Duiverman EJ. Sample size estimation for monitoring exercise-induced bronchoconstriction in asthmatic children. Thorax 1997;52:739-741.
25. Sterk PJ, Fabbri LM, Quanjer PhH, Cockcroft DW, O'Byrne PM, Anderson SD, Juniper EF, Malo J-L. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J [Suppl] 1993;6:53-83.
26. Eggleston PA, Guerrant JL. A standardized method of evaluating exercise-induced asthma. J Allergy Clin Immunol 1976;58:414-425.
27. Duiverman EJ, Neyens HJ, Van der Snee-van Smaalen M, Kerrebijn KF. Comparison of forced oscillometry and forced expirations for measuring dose-related responses to inhaled methacholine in asthmatic children. Bull Eur Physiopathol Respir 1986;22: 433-436.
28. Peterson CGB, Enander I, Nystrand J, Anderson AS, Nilsson L, Venge P. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 1991;21:561-567.
29. O'Connor BJ, Ridge SM, Barnes PJ, Fuller RW. Greater effect of inhaled budesonide on adenosine 5′-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma. Am Rev Respir Dis 1992;146:560-564.
30. Kerstjens HAM, Brand PLP, Hughes MD, Robinson RJ, Postma DS, Sluiter HJ. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992;327:1413-1419.
31. Selroos O, Pietinalho A, Riska H. Delivery devices for inhaled asthma medication. Clinical implications of differences in effectiveness. Clin Immunother 1996;6:273-299.
32. -1. Eur Respir J 1996;9:2263-2272.
33. Carlsen K-H, Larsson K. The efficacy of inhaled disodium cromoglycate and glucocorticosteroids. Clin Exp Allergy [Suppl] 1996;26:8-17.
34. Olivieri D, Chetta A, Del Donno M, Bertorelli G, Casalini A, Pesci A, Testi R, Foresi A. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997;155:1864-1871.
35. Sont JK, Van Krieken JHJM. Evertse CE, Hooijer R, Willems LNA, Sterk PJ. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 1996;51:496-502.
36. Macklem PT. A theoretical analysis of the effect of airway smooth muscle load on airway narrowing. Am J Respir Crit Care Med 1996;153:83-89.
37. Greiff L, Anderson M, Svensson S, Alkner U, Persson CGA. Glucocorticosteroids may not inhibit plasma exudation by direct vascular antipermeability effects in human airways. Eur Respir J 1994;7:1120-1124.
38. Sont JK, Willemse LNA, Bel EH, Van Krieken JHJM, Vandenbroucke JP, Sterk PJ. Clinical control and histopathological outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999;159:1043-1051.
39. Benckhuijsen J, Van den Bos JW, Van Velzen E, De Bruijn R, Aalbers R. Differences in the effect of allergen avoidance on bronchial hyperresponsiveness as measured by methacholine, adenosine 5′-monophosphate, and exercise in asthmatic children. Pediatr Pulmonol 1996;22:147-153.
40. Fitch KD, Blitvich JD, Morton AR. The effect of running training on exercise-induced asthma. Ann Allergy 1986;57:90-94.
41. Pedersen S, Warner JO, Price JF. Early use of inhaled steroids in children with asthma. Clin Exp Allergy 1997;27:995-1006.